Valacyclovir starts working within hours of your first dose, but visible improvement takes longer. Most people notice a reduction in pain and discomfort within one to three days. In clinical trials, valacyclovir shortened the total duration of a cold sore episode by about one day compared to no treatment, with a median healing time that brought many people from outbreak to resolution roughly a day sooner than they would have healed on their own.
The First 24 Hours Matter Most
Valacyclovir works by stopping the herpes virus from copying itself. Once your body absorbs it, the drug is converted into its active form, which gets taken up preferentially by infected cells. Inside those cells, it mimics one of the building blocks the virus needs to replicate its DNA. When the virus tries to use it, the replication process stalls and the viral DNA chain can’t grow. This means valacyclovir doesn’t kill the virus directly. It stops it from multiplying, which limits how large and painful the outbreak becomes.
Because the drug works by blocking replication, timing is everything. You need to take it while the virus is still actively ramping up, not after it has already done its damage. The FDA-approved dosing for cold sores is 2 grams twice in a single day, with the two doses taken 12 hours apart. You should take the first dose at the earliest prodromal symptom: that familiar tingling, itching, or burning sensation before a blister appears. In clinical trials, most participants started treatment within two hours of noticing symptoms.
Once a visible sore has already formed (a raised bump, blister, or open ulcer), the drug’s effectiveness drops significantly. The FDA label states that efficacy has not been established if treatment begins after clinical signs of a cold sore have developed. In practical terms, if you’ve already got a full blister, valacyclovir may still offer some benefit, but you’ve missed the window where it can meaningfully shorten the outbreak or potentially prevent a sore from forming at all.
Realistic Healing Timeline
Two large, placebo-controlled studies published in Antimicrobial Agents and Chemotherapy tested the one-day valacyclovir regimen against a placebo. The primary finding: the one-day treatment reduced the median episode duration by one full day and the mean duration by 1.1 days. A two-day regimen performed slightly worse, shortening episodes by only half a day on average. Both the time to lesion healing and the time to pain relief were statistically shorter with valacyclovir compared to placebo.
A one-day improvement might sound modest, but cold sore episodes typically last 7 to 10 days without treatment. Shaving a day off the worst phase, when the sore is most visible and painful, is meaningful in daily life. Some people who take the drug early enough during the prodrome stage may prevent a blister from ever fully forming, though this outcome isn’t guaranteed.
For symptom relief specifically, expect up to three days before you feel a clear reduction in pain, burning, or itching. The drug doesn’t numb pain directly. It limits how much new virus is produced, which in turn limits tissue damage and inflammation. Your immune system still needs time to clean up the outbreak.
How Valacyclovir Compares to Acyclovir
Valacyclovir is actually a prodrug of acyclovir, meaning your liver converts it into acyclovir after you swallow it. The key advantage is better absorption. More of the active drug reaches your bloodstream compared to taking acyclovir directly, which means it stays in your system longer and requires fewer doses per day. For cold sores, valacyclovir’s simple two-dose, one-day regimen is far more convenient than acyclovir’s more frequent dosing schedule.
Head-to-head studies comparing the two drugs specifically for cold sores are limited. For shingles (caused by a related herpes virus), one large study with over 1,000 participants found valacyclovir resolved symptoms in 38 days versus 51 days for acyclovir. While that data doesn’t translate directly to cold sores, it supports the idea that valacyclovir’s superior absorption offers a real clinical advantage.
Reducing Transmission Risk
Cold sores are most contagious when blisters are open and weeping, but the virus can shed even before visible sores appear. Valacyclovir reduces viral shedding, which is why it’s also used as daily suppressive therapy for people with frequent outbreaks. The CDC notes that daily suppressive dosing decreases the rate of herpes transmission in couples where one partner carries the virus. For recurrent outbreaks, suppressive therapy reduces flare-ups by 70% to 80%.
Even after starting treatment, you should assume you’re contagious until the sore has completely crusted over and healed. Avoid kissing, sharing utensils, and direct skin contact around the affected area during an active outbreak.
Who Can Take It
Valacyclovir is FDA-approved for cold sore treatment in adults and adolescents aged 12 and older, using the same dosing: 2 grams twice in one day, 12 hours apart. Its safety and effectiveness have not been established for children under 12 for this specific use.
The drug is generally well tolerated. The most common side effects are headache and nausea, and since the treatment course is just one day for cold sores, side effects tend to be brief. If you get cold sores frequently (six or more times per year), a daily suppressive regimen at a lower dose may be worth discussing, as it can dramatically reduce both the frequency of outbreaks and the risk of passing the virus to others.